Feasibility and Effects of KOL-webben in Patients With COPD
Launched by UMEÅ UNIVERSITY · Feb 25, 2016
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Pulmonary rehabilitation is a cornerstone in the management of patients with chronic obstructive pulmonary disease (COPD) and includes self-management strategies and exercise training. Pulmonary rehabilitation has been shown to decrease dyspnea, improve physical capacity, level of physical activity and health-related quality of life. Traditionally patients with COPD have been treated at pulmonary or medical departments in hospitals. However, due to changes in the Swedish health system these patients now are mainly treated in primary care. Though, the pulmonary rehabilitation programs are st...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 40 years and above diagnosed with COPD according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) \< 0.70.
- • Needs to understand Swedish or have access to anyone who understands Swedish.
- Exclusion Criteria:
- • Not COPD
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Umeå, , Sweden
Patients applied
Trial Officials
Karin Wadell, PhD
Principal Investigator
Umeå University
Andre Nyberg, PhD
Study Director
Umeå University
Malin Tistad, PhD
Study Director
Umeå University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials